Details

Targeting brain tumors with enough anti-cancer medication is no easy task. But Stefan Bossmann and Deryl Troyer at Kansas State University are developing a novel materials treatment method for persons with brain cancer that uses a type of white blood cell to deliver anticancer drugs to particularly virulent brain tumors.

Credits at end of video